Regenerative medicine (RM) holds immense promise, particularly in regenerative ophthalmology (RO). Pioneering therapies are under investigation for disorders like AMD and congenital degenerations. RO aims to restore function through biomaterials, cells, and bioactive substances, regenerating tissues and organs. These innovative techniques could enhance ocular disease management. Leveraging tissue engineering, RO focuses on regenerating lost or injured eye tissues to address visual impairment and blindness caused by degenerative disorders, trauma, or infection.